Morgan Stanley’s Alaunos Therapeutics TCRT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$8.72K Buy
1,798
+901
+100% +$4.37K ﹤0.01% 6896
2025
Q1
$1.32K Sell
897
-149
-14% -$219 ﹤0.01% 7247
2024
Q4
$1.99K Sell
1,046
-291
-22% -$554 ﹤0.01% 7200
2024
Q3
$4.31K Sell
1,337
-157
-11% -$506 ﹤0.01% 6952
2024
Q2
$10.4K Sell
1,494
-216
-13% -$1.51K ﹤0.01% 6668
2024
Q1
$30.9K Sell
1,710
-1,553
-48% -$28.1K ﹤0.01% 6369
2023
Q4
$34.6K Buy
3,263
+1,080
+49% +$11.5K ﹤0.01% 6477
2023
Q3
$43.2K Sell
2,183
-1,865
-46% -$36.9K ﹤0.01% 6228
2023
Q2
$310K Sell
4,048
-375
-8% -$28.7K ﹤0.01% 5453
2023
Q1
$418K Sell
4,423
-5,043
-53% -$477K ﹤0.01% 5355
2022
Q4
$922K Buy
9,466
+4,493
+90% +$437K ﹤0.01% 4915
2022
Q3
$1.28M Sell
4,973
-874
-15% -$225K ﹤0.01% 4733
2022
Q2
$1.09M Sell
5,847
-570
-9% -$106K ﹤0.01% 4961
2022
Q1
$628K Buy
6,417
+422
+7% +$41.3K ﹤0.01% 5275
2021
Q4
$981K Sell
5,995
-308
-5% -$50.4K ﹤0.01% 5079
2021
Q3
$1.72M Sell
6,303
-673
-10% -$184K ﹤0.01% 4683
2021
Q2
$2.76M Buy
6,976
+815
+13% +$323K ﹤0.01% 4368
2021
Q1
$3.33M Sell
6,161
-2,145
-26% -$1.16M ﹤0.01% 3830
2020
Q4
$3.14M Buy
8,306
+2,399
+41% +$907K ﹤0.01% 3765
2020
Q3
$2.23M Sell
5,907
-252
-4% -$95.3K ﹤0.01% 3559
2020
Q2
$3.03M Sell
6,159
-2,772
-31% -$1.36M ﹤0.01% 3180
2020
Q1
$3.28M Buy
8,931
+1,060
+13% +$390K ﹤0.01% 2874
2019
Q4
$5.57M Sell
7,871
-3,183
-29% -$2.25M ﹤0.01% 3085
2019
Q3
$7.1M Buy
11,054
+1,820
+20% +$1.17M ﹤0.01% 2488
2019
Q2
$8.08M Buy
9,234
+1,079
+13% +$944K ﹤0.01% 2392
2019
Q1
$4.71M Sell
8,155
-1,354
-14% -$782K ﹤0.01% 2773
2018
Q4
$2.67M Buy
9,509
+1,673
+21% +$469K ﹤0.01% 3529
2018
Q3
$3.76M Sell
7,836
-614
-7% -$295K ﹤0.01% 3481
2018
Q2
$3.83M Sell
8,450
-630
-7% -$285K ﹤0.01% 3455
2018
Q1
$5.34M Sell
9,080
-942
-9% -$554K ﹤0.01% 2964
2017
Q4
$6.22M Buy
10,022
+1,038
+12% +$645K ﹤0.01% 2856
2017
Q3
$8.27M Sell
8,984
-533
-6% -$491K ﹤0.01% 2475
2017
Q2
$8.88M Sell
9,517
-3,744
-28% -$3.49M ﹤0.01% 2283
2017
Q1
$12.6M Buy
13,261
+2,165
+20% +$2.06M ﹤0.01% 1982
2016
Q4
$8.9M Buy
11,096
+1,814
+20% +$1.46M ﹤0.01% 2378
2016
Q3
$7.84M Sell
9,282
-71
-0.8% -$60K ﹤0.01% 2230
2016
Q2
$7.7M Buy
9,353
+46
+0.5% +$37.9K ﹤0.01% 2204
2016
Q1
$10.4M Sell
9,307
-1,481
-14% -$1.65M ﹤0.01% 1832
2015
Q4
$13.4M Buy
10,788
+524
+5% +$653K ﹤0.01% 1740
2015
Q3
$13.9M Buy
10,264
+170
+2% +$230K 0.01% 1677
2015
Q2
$18.2M Buy
10,094
+990
+11% +$1.78M 0.01% 1580
2015
Q1
$14.7M Buy
9,104
+281
+3% +$454K 0.01% 1705
2014
Q4
$6.71M Buy
8,823
+338
+4% +$257K ﹤0.01% 2438
2014
Q3
$3.36M Buy
8,485
+562
+7% +$222K ﹤0.01% 3000
2014
Q2
$4.79M Buy
7,923
+193
+2% +$117K ﹤0.01% 2705
2014
Q1
$5.31M Buy
7,730
+804
+12% +$552K ﹤0.01% 2527
2013
Q4
$4.51M Buy
6,926
+2,387
+53% +$1.55M ﹤0.01% 2668
2013
Q3
$2.68M Buy
4,539
+917
+25% +$542K ﹤0.01% 2991
2013
Q2
$1.15M Buy
+3,622
New +$1.15M ﹤0.01% 3616